These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Diabetic neuropathy--a review of pathological studies]. Kito S; Yamamura Y Nihon Rinsho; 1991 Feb; 49 Suppl():152-8. PubMed ID: 1851895 [No Abstract] [Full Text] [Related]
6. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330 [TBL] [Abstract][Full Text] [Related]
7. [Disorders of sorbitol and myoinositol metabolism and the activity of sodium, potassium ATPase in the pathogenesis of peripheral neuropathy in patients with diabetes mellitus]. Mosiewicz J; Grzywa M Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):56-8. PubMed ID: 1329048 [TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of diabetic neuropathy. N Engl J Med; 1989 Jan; 320(1):57-60. PubMed ID: 2909880 [No Abstract] [Full Text] [Related]
9. [Contemporary views on the pathogenesis of diabetic neuropathy]. Pierzchala K Wiad Lek; 1998; 51 Suppl 2():30-4. PubMed ID: 9686530 [TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism. Greene DA; Lattimer-Greene S; Sima AA Crit Rev Neurobiol; 1989; 5(2):143-219. PubMed ID: 2561904 [TBL] [Abstract][Full Text] [Related]
12. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats]. Lu KM; Zhong XL; Zhu XX; Zhu QY Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949 [TBL] [Abstract][Full Text] [Related]
13. Polyols and myo-inositol in diabetic neuropathy--of mice and men. Tomlinson DR Mayo Clin Proc; 1989 Aug; 64(8):1030-3. PubMed ID: 2796398 [No Abstract] [Full Text] [Related]
14. [Sorbitol, phosphoinositides and Na K-ATPase in the pathogenesis of diabetic complications]. Greene DA; Sima AA; Lattimer SA Journ Annu Diabetol Hotel Dieu; 1988; ():105-17. PubMed ID: 2845181 [No Abstract] [Full Text] [Related]
15. Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Greene DA; Lattimer S; Ulbrecht J; Carroll P Diabetes Care; 1985; 8(3):290-9. PubMed ID: 2988888 [TBL] [Abstract][Full Text] [Related]
16. [Diabetic neuropathy: theories on its metabolic pathogenesis]. Gregersen G Ugeskr Laeger; 1987 Nov; 149(46):3110-1. PubMed ID: 3328355 [No Abstract] [Full Text] [Related]
17. Has one diabetic complication been explained? Winegrad AI; Simmons DA; Martin DB N Engl J Med; 1983 Jan; 308(3):152-4. PubMed ID: 6848907 [No Abstract] [Full Text] [Related]
18. [Metabolic factors in the pathogenesis of diabetic neuropathies]. Hamada Y Nihon Rinsho; 2005 Jun; 63 Suppl 6():504-8. PubMed ID: 15999760 [No Abstract] [Full Text] [Related]
19. [Diabetic neuropathy and the sorbitol cycle]. Ide T Nihon Rinsho; 1969 Sep; 27(9):2350-4. PubMed ID: 5389229 [No Abstract] [Full Text] [Related]
20. Diabetic polyneuropathy: the importance of insulin deficiency, hyperglycemia and alterations in myoinositol metabolism in its pathogenesis. Winegrad AI; Greene DA N Engl J Med; 1976 Dec; 295(25):1416-21. PubMed ID: 980097 [No Abstract] [Full Text] [Related] [Next] [New Search]